WAVEMAN · COMPANY

GPRE · Green Plains Inc.

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

GPRE

Name: Green Plains Inc. (GPRE) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Green Plains Inc.

PHARMA & BIOTECH · INDUSTRIAL ORGANIC CHEMICALS · CIK 0001309402

SEC FILINGS☆ WATCH

INSIDER NET · 180D

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

118

13F, latest reported quarter

REVENUE GROWTH

+16.0%

XBRL, annual

NET MARGIN

-64.2%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

no Form 4 purchases or sales on file

CONGRESS

no member of Congress has reported trading it

FUNDS

118 funds added or opened last quarter

more than 71% of Pharma & Biotech

REVENUE

+16.0% year over year

more than 65% of Pharma & Biotech

MARGIN

-64.2% net margin

below 60% of Pharma & Biotech

BUYBACKS

$30.0M repurchased, FY to 2025-12-31

below 54% of Pharma & Biotech

SHORT

18.6% of shares outstanding short · 8.5 days to cover · settled 2026-07-31

more than 94% of Pharma & Biotech

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

118 funds added or opened positions in the latest 13F quarter, of 224 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +35.9%

+35.9%12M

INSIDER BUYINSIDER SELL

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows 118 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for Green Plains Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

Sweeney Patrick Francis

Director

BUY

2026-03-06

6,383.0

$101.3K

MAPES MICHELLE

Chief Legal and Admin Officer

SELL

2025-09-22

30,954.0

$294.4K

Treuer Alain

Director

SELL

2024-02-20

22,999.0

$521.2K

Knudsen Ejnar A III

Director

BUY

2024-02-12

4,000.0

$98.9K

Becker Todd A

President and CEO

BUY

2023-12-11

960.0

$23.7K

22 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 17 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

10,188,770.0 sh

$156.7M

GOLDMAN SACHS GROUP INC

4,023,439.0 sh

$61.9M

Grantham, Mayo, Van Otterloo & Co. LLC

3,898,967.0 sh

$60.0M

STATE STREET CORP

3,748,374.0 sh

$57.6M

VANGUARD CAPITAL MANAGEMENT LLC

2,986,521.0 sh

$45.9M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

GMO Resource Transition Fund

$3.8M POSITION · AS OF 2026-02-28

2.1%

GMO Climate Change Fund

$12.0M POSITION · AS OF 2026-02-28

1.9%

FundX Future Fund Opportunities ETF

$3.4M POSITION · AS OF 2026-03-31

1.7%

GMO Resources Fund

$17.0M POSITION · AS OF 2026-02-28

1.3%

ALPS Clean Energy ETF

$1.4M POSITION · AS OF 2026-02-28

1.2%

Invesco Dorsey Wright Energy Momentum ETF

$1.0M POSITION · AS OF 2026-04-30

1.2%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Corporate PAC

FEC · the company-connected political action committee's own receipts and spending — committee totals only, never individual donors

Green Plains Inc. Pac

CYCLE 2026 · $2K SPENT

$3.1K

FEDERAL ELECTION COMMISSION · MATCHED BY THE PAC'S CONNECTED ORGANISATION

Executive pay vs shareholder return · Mr. Osowski

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2024

$5.7M

-$437.5K

$1.3M

-28%

-50%

2023

$5.6M

$3.6M

$1.3M

+92%

-39%

2022

$5.9M

$3.5M

$1.3M

+132%

-32%

2021

$5.9M

$16.2M

$1.4M

+164%

-3%

2020

$3.1M

$4.7M

$870.1K

-15%

+185%

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$189.0M	$163.0M	$136.3M	$78.6M
GROSS PROFIT	$136.9M	$130.4M	$164.8M	$112.7M
OPERATING INCOME	$-67.2M	$-47.5M	$-61.6M	$-98.9M
NET INCOME	$-121.0M	$-81.2M	$-76.3M	$-103.4M
EPS (DILUTED)	-1.80	-1.29	-1.59	-2.29
OPERATING CASH FLOW	$110.9M	$-30.0M	$56.3M	$69.7M
CASH	$182.3M	$173.0M	$349.6M	$444.7M
LONG-TERM DEBT	$362.0M	$432.5M	$491.9M	$495.2M
BUYBACKS	$30.0M	$0	$0	$0
DIVIDENDS PAID	$721.0K	$5.2M	$22.7M	$22.6M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE